SWOG has nearly 12,000 members in 47 states and eight other countries who design ... LBL have dismal outcomes and may receive similar treatments to relapsed or refractory T-ALL patients. About OBI ...

CTD402 is a universal CAR-T cell product targeting CD7 derived from healthy donors and intended for the treatment of T-ALL/LBL. It is genetically modified to avoid fratricide, graft-versus-host ...

SWOG has nearly 12,000 members in 47 states and eight other countries who design ... LBL have dismal outcomes and may receive similar treatments to relapsed or refractory T-ALL patients. About OBI ...